IL6 and vasculitis: In particular, iatrogenic hyperglycemia can lead to impaired wound healing, neuronal dysfunction, increased production of the inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), inhibition of leukocyte function, vasculitis, and ultimately a poorer clinical outcome (8–13).